Claudia Guepet, FNP-C , a provider at Rejuvime Medical in Metairie, Louisiana , specializes in medically supervised weight loss and has guided many patients through GLP1based treatment plans
Gault VA, Kerr BD, Harriott P, Flatt PR
When examining the data, researchers found that GLP-1RA agents showed potential as adjunctive therapies for psoriasis, particularly for patients with obesity, type 2 diabetes, or cardiometabolic risk
Thus, it is clear that the focus is not solely on glycemic regulation, but rather on immunometabolism, leading to possible depression onset
That means we do not yet know who may respond, what dose or duration would matter, or whether any changes are sustained over time
Semaglutide (Wegovy) and tirzepatide (Zepbound) have demonstrated significant average weight loss14.9% and 20.9% of body weight at approximately one year, respectively